Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/13/2000 | CA2345817A1 Novel methods for therapeutic vaccination |
04/13/2000 | CA2345615A1 Novel g protein-coupled receptor protein and dna thereof |
04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
04/13/2000 | CA2345440A1 Genes differentially expressed in cancer cells to design cancer vaccines |
04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
04/13/2000 | CA2345215A1 Fusions of scaffold proteins with random peptide libraries |
04/13/2000 | CA2345214A1 Tissue binding peptides, identification, production and utilization thereof |
04/13/2000 | CA2345209A1 Antisense modulation of integrin .alpha.4 expression |
04/13/2000 | CA2345203A1 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
04/13/2000 | CA2345045A1 G-protein coupled receptor proteins |
04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
04/13/2000 | CA2345000A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
04/13/2000 | CA2344976A1 Novel g-protein-coupled receptor protein and its dna |
04/13/2000 | CA2344973A1 Oxidoreductase molecules |
04/13/2000 | CA2344765A1 Novel peptides |
04/13/2000 | CA2344616A1 Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (tnf-.alpha.) expression |
04/13/2000 | CA2344593A1 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
04/13/2000 | CA2344552A1 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
04/13/2000 | CA2344551A1 P-conotoxin peptide |
04/13/2000 | CA2344468A1 Method for preparing high performance reca-like recombinase/single-stranded nucleic acid probe complex and utilization thereof |
04/13/2000 | CA2344459A1 Novel g protein-coupled receptor protein and dna thereof |
04/13/2000 | CA2344456A1 Ptans: testis specific proteins expressed in prostate cancer |
04/13/2000 | CA2344269A1 Therapeutically active proteins in plants |
04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
04/13/2000 | CA2343734A1 Commercial production of laccase in plants |
04/13/2000 | CA2341351A1 Alpha-2/delta gene |
04/13/2000 | CA2340333A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use |
04/13/2000 | CA2335391A1 Akt compositions for enhancing survival of cells |
04/13/2000 | CA2313169A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
04/13/2000 | CA2284850A1 Dna coding for protein which confers on bacterium escherichia coli resistance to l-homoserine, and method for producing l-amino acids |
04/12/2000 | EP0992588A1 DsbA/DsbB/DsbC/DsbD expression plasmid |
04/12/2000 | EP0992587A2 High affinity IP3-binding polypeptide |
04/12/2000 | EP0992586A2 Extracellular matrix proteins with modified amino acid |
04/12/2000 | EP0992585A2 Human calcium channel compositions and methods |
04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
04/12/2000 | EP0992583A1 Novel method for purifying covalently closed circular DNA |
04/12/2000 | EP0992581A2 Immunodominant human T-cell epitopes of hepatitis C virus |
04/12/2000 | EP0992580A2 Immunodominant human T-cell epitopes of Hepatitis C virus |
04/12/2000 | EP0992579A1 Stem cell factor |
04/12/2000 | EP0992577A1 Process for microinjection and nanopipette for introducing an injection product, particularly foreign genetic material in procaryotic or eucaryotic cells or cellcomparments thereof (plastides, cell nucleus) |
04/12/2000 | EP0992512A2 Reduced cortisol conjugate |
04/12/2000 | EP0992189A1 Animals carrying 25-hydroxylated vitamin d3-24-hydroxylase gene transferred thereinto |
04/12/2000 | EP0991946A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
04/12/2000 | EP0991782A2 Nucleic acid primers and probes for detecting hiv-1 and hiv-2 |
04/12/2000 | EP0991781A2 GROUP OF NUCLEIC ACID MOLECULES FOR $i(SALMONELLA) DETECTION, NUCLEIC ACIDS, KIT AND USE |
04/12/2000 | EP0991779A1 Improved detection of mutations in nucleic acids by chemical cleavage |
04/12/2000 | EP0991775A1 Method to identify pesticidal microbes |
04/12/2000 | EP0991774A1 Method for increasing secretion of proteins in eukaryotic host cells |
04/12/2000 | EP0991771A2 Lentivirus based vector and vector system |
04/12/2000 | EP0991770A2 Prostate cancer gene |
04/12/2000 | EP0991769A2 A method for plant protection against insects or nematodes |
04/12/2000 | EP0991768A1 Sucrose-binding proteins |
04/12/2000 | EP0991767A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components |
04/12/2000 | EP0991766A1 Regulation of quinolate phosphoribosyl transferase expression |
04/12/2000 | EP0991765A1 Resistance marker for monocotyledons |
04/12/2000 | EP0991764A1 Regulatory sequences for transgenic plants |
04/12/2000 | EP0991762A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
04/12/2000 | EP0991761A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
04/12/2000 | EP0991758A1 Smad6 and uses thereof |
04/12/2000 | EP0991757A1 Novel tumor antigens |
04/12/2000 | EP0991756A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
04/12/2000 | EP0991755A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
04/12/2000 | EP0991754A2 Proteases from gram-positive organisms |
04/12/2000 | EP0991665A1 Peptides and compounds that bind to the il-5 receptor |
04/12/2000 | EP0991663A1 $i(MYCOBACTERIUM) STRAIN WITH MODIFIED $i(ERP) GENE AND VACCINE COMPOSITION CONTAINING SAME |
04/12/2000 | EP0991661A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
04/12/2000 | EP0991659A1 Peptides and compounds that bind to the il-5 receptor |
04/12/2000 | EP0991456A1 One step device and process for concentration and purification of biological molecules |
04/12/2000 | EP0991425A1 Pro |
04/12/2000 | EP0991421A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease |
04/12/2000 | EP0991417A1 Complex formation between dsdna and oligomer of heterocycles |
04/12/2000 | EP0991385A2 Autoimmune inner ear disease antigen and diagnostic assay |
04/12/2000 | EP0991321A1 Tolerance to natural antibody antigens |
04/12/2000 | EP0868535B1 Methods and compositions for determining the sequence of nucleic acid molecules |
04/12/2000 | EP0832293B1 Method for detecting heat-resistant micro-organisms capable of contaminating certain food products |
04/12/2000 | EP0814838A4 Antigen presenting system and methods for activation of t-cells |
04/12/2000 | EP0804414A4 Complementary dna and toxins |
04/12/2000 | EP0676052B1 Detection of cystic fibrosis or a cftr gene mutation |
04/12/2000 | EP0452413B1 Generation and selection of novel dna-binding proteins and polypeptides |
04/12/2000 | EP0362218B2 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
04/12/2000 | CN1250485A Method and compositions for detection or quantification of nucleic acid spcies |
04/12/2000 | CN1250484A Diagnosis and treatment of glaucoma |
04/12/2000 | CN1250483A Mass label linked hybridisation probes |
04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
04/12/2000 | CN1250478A A gene homologous to fox sperm acrosomal protein FSA-1 (CBCALD05) |
04/12/2000 | CN1250477A Tissue specific promoters |
04/12/2000 | CN1250476A Process for producing L-methionine 'gamma'-lyase crystals |
04/12/2000 | CN1250102A Process for preparing fermented product and stress resistance microbe |
04/12/2000 | CN1250100A Supersonic wave pollen treating process to induce plant's gene transfer |
04/12/2000 | CN1250099A Human gene hBIF to regulate the activity of hepatitis B virus enhancer II |
04/12/2000 | CN1250098A Human P47 coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250097A New human gene coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250096A New human protein phosphatase subunit and its coding series and preparation |
04/12/2000 | CN1250095A New human gene series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250094A New human kernon acceptor co-repressor coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250055A Production of recombination human lactoferritin |